Profound Medical PROF Capital Equipment — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Profound Medical in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Profound Medical's capital equipment — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Profound Medical's capital equipment — revenue?
- Profound Medical (PROF) reported capital equipment — revenue of $2.86M in Q1 2026.
- How has Profound Medical's capital equipment — revenue changed year-over-year?
- Profound Medical's capital equipment — revenue increased by 249.1% year-over-year, from $820K to $2.86M.
- What is the long-term trend for Profound Medical's capital equipment — revenue?
- Over 2 years (2023 to 2025), Profound Medical's capital equipment — revenue has grown at a 302.5% compound annual growth rate (CAGR), from $393K to $6.37M.
- What does capital equipment — revenue mean?
- This metric represents the total revenue generated from the direct sale or lease of primary medical hardware systems and associated capital equipment. It reflects the company's ability to successfully place its core therapeutic platforms within clinical environments and serves as a key indicator of market adoption for its image-guided ablation technology. Growth in this segment highlights the expansion of the installed base, which typically precedes recurring revenue streams from disposables and service contracts.